Close Close

Life Health > Health Insurance > Health Insurance

FDA panel urges looser restrictions on diabetes drug Avandia

Your article was successfully shared with the contacts you provided.

Despite lingering concerns about increased susceptibility to heart problems when taking Avandia, a Type 2 diabetes medication, the majority of a Federal Drug Administration advisory panel suggested that the drug have looser restrictions. It will now be up to FDA Commissioner Margaret Hamburg to make a decision.